Alternative names, keywords |
N-terminal pro B-type natriuretic peptide, BNP |
||||||||||||||||||
Samples required |
|
||||||||||||||||||
Test indications |
|||||||||||||||||||
Factors affecting test performance/ results |
Samples should not be taken from patients receiving therapy with high biotin doses (i.e. > 5 mg/day) until at least 8 hours following the last biotin administration. In rare cases, interference due to extremely high titres of antibodies to analyte-specific antibodies, streptavidin or ruthenium can occur. In extremely rare cases (global incidence: < 1 in 10 million), patients may show discrepant results when tested with the assay kit (values below lower detection limit) due to a NT-proBNP genetic variant. Results should always be assessed in conjunction with the patient’s medical history, clinical examination and other findings. |
||||||||||||||||||
Reference range |
Reference ranges (see below for clinical cut-offs):
Source: Roche Cobas® N-terminal pro B-type natriuretic peptide kit insert 02-2015, V9.0 Non-HF causes of high NTproBNP: LVH, ischaemia, tachycardia, RV overload, hypoxaemia (including pulmonary embolism), renal dysfunction (GFR < 60 ml/min), sepsis, COPD, diabetes, age > 70 years, cirrhosis of the liver. |
||||||||||||||||||
|
From NICE guideline NG106 Chronic heart failure in adults: diagnosis and management (published September 2012), for patients with suspected heart failure:
|
||||||||||||||||||
Turnaround time |
RSCH same day, PRH within 24h. |
||||||||||||||||||
Enquiries |
Biochemistry (Automation) |